Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CAMS Oxford Institute unveiled at virtual ceremony

Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.

Protease inhibitors safer than thought for pregnant women with HIV

University of Oxford researchers assessed evidence from 34 studies, involving over 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of babies being small or very small for their gestational age, but there were no other adverse pregnancy outcomes, compared to therapies without protease inhibitors.

Oxford men's crew claim victory in 2022 Boat Race after Cambridge women’s win

Oxford’s men’s crew won the 2022 Gemini Boat Race as it returned to the Tideway this year, where Cambridge claimed victory in the women’s race in a new record time.

No increased risk of brain tumours for mobile phone users, new study finds

Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.

Little understood brain region linked to how we perceive pain

A new review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.

Oxford launches new Bennett Institute for Applied Data Science

The use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine.

Largest genetic study of pleural infection reveals complex nature of common disease

A new genetic study of the bacteria that cause pleurisy has shown most cases involve more than one type of bacterium, and revealed which bacterial combinations cause the most serious infections.

First UK pilot study of newborn screening for spinal muscular atrophy launched in Oxford

In the UK, every five days a baby is born with spinal muscular atrophy (SMA). Treatments are available now. If these treatments are delivered at birth, these newborns have the best chance of living long and healthy lives. If treated later, when they are identified because of the symptoms, they may survive, but with a severe disability. So, for every 5 days that a newborn screening is delayed, a baby in the UK loses the chance of a brighter future.

Oxford further commits to best research practice by joining UKRN

The University of Oxford has become an institutional member of the UK Reproducibility Network (UKRN), a national peer-led initiative that brings together researchers and stakeholders across the sector to ensure coordination of efforts to improve the quality of research and its trustworthiness.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Professor Lynne Cox helps lead UK project to transform older age health

Professor Lynne Cox of the Department of Biochemistry will co-lead a new national research network focused on transforming the health of older people and boosting the economy.

Brain regions related to smell show decline following mild COVID-19

Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.

Rabies vaccine candidate begins human trials in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory treatment normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19.

COVID-19 Multi-omic Blood Atlas (COMBAT) published

The COVID-19 Multi-omic Blood Atlas (COMBAT) defines hallmarks of disease severity and specificity.

New study shows significant impacts of severe COVID-19 infection on pregnancy outcomes

A new analysis from Oxford Population Health has found that pregnant women that are 30 years old or more, overweight, of mixed ethnicity or have gestational diabetes have a greater risk of contracting severe COVID-19, which poses significant risks for both mother and baby.

New Oxford-Lancaster guidelines to improve practice when babies are separated from parents at birth

Draft guidelines to help improve practice when the state acts to safeguard a baby at birth have been created by researchers at Oxford (the Rees Centre) and Lancaster Universities - and are being tested across England and Wales.

Researchers find genetic ‘fingerprints’ of ancient migrations in modern-day United Arab Emirates

A team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID impact on the cardiovascular system.

Load More